Velaparthi, Upender <br/><br/>
Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent.  [electronic resource] 

 -  ACS medicinal chemistry letters  Feb 2020 
 - 172-178 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1948-5875 
<br/><br/><label>Standard No.: </label>10.1021/acsmedchemlett.9b00552  doi